Welcome to our dedicated page for Syntec Optics Holdings news (Ticker: OPTX), a resource for investors and traders seeking the latest updates and insights on Syntec Optics Holdings stock.
Syntec Optics Holdings, Inc. develops and manufactures precision optics and photonics products for defense, biomedical, communications and consumer end markets. The company’s vertically integrated capabilities include design, toolmaking, glass and polymer molding, thin-film coatings, nano machining, optical assemblies, opto-electronic assemblies and imaging module integration.
News about Syntec Optics commonly covers production scaling, purchase orders and product-line activity in areas such as Low Earth Orbit satellite optics, night-vision optics, integrated optical assemblies, biomedical optics, AI data center optics and micro cameras for augmented-reality defense systems. Company updates also include operating and financial results, domestic supply-chain positioning, shareholder voting matters and capital actions involving its Nasdaq-listed common stock.
Syntec Optics (Nasdaq: OPTX) reported record Q2 2026 revenue of $8.3 million, up 26% year over year, driven by strong growth in communications (+74%), defense (+36%), and consumer (+23%) markets. Gross profit rose 34% to $2.1 million, with gross margin expanding to 26% versus 24% a year ago and 15% in Q1 2026.
The company generated Q2 operating income of $0.3 million and net income of $0.3 million ($0.01 per share), compared with a net loss in the prior-year quarter. Syntec Optics ended June 30, 2026 with $14.0 million in cash after a public equity offering delivering $21.4 million net proceeds and repayment of about $6.8 million of debt, eliminating its revolving credit line and cutting total liabilities by roughly 43%. Management guided Q3 2026 revenue to $8.3–$9.0 million and Q4 2026 revenue to $8.75–$9.25 million.
Syntec Optics (Nasdaq: OPTX) announced a new recurring fusion energy optics order that it describes as worth about seven times the fusion orders received late last year. The company will supply special high-precision optics used in compact, high-temperature fusion reactors.
According to Syntec Optics, total orders tied to AI data centers, including fusion-related optics, micro-connectors, and space-power subsystems, have reached $4 million over the past two years. To support this demand, Syntec is dedicating 5% of its factory capacity to AI data center optics production.
Syntec Optics (NASDAQ: OPTX) announced a major new production order to launch an additional space optics product line focused on advanced collision-avoidance optics for low Earth orbit satellites. The company previously supplied preforms for such systems and will now manufacture the complete, ultra-precise optics that act as “eyes” for satellites, enabling real-time debris detection and avoidance.
According to Syntec Optics, this builds on its track record of producing thousands of satellite optics links and leverages its high-volume manufacturing capability. Headquartered in Rochester with nearly 180 employees, Syntec serves defense, space and other photonics end-markets within the broader $16 trillion light-enabled economy.
Syntec Optics (Nasdaq: OPTX) announced its inclusion in the Russell 3000® Index, with the final, fully validated list of index members implemented at the opening of U.S. equity markets on June 29, 2026. The company is scheduled to receive education on the Russell indexes on July 24, 2026.
According to Syntec Optics, FTSE Russell evaluated publicly listed companies and determined that Syntec Optics should be tracked nationally within the Russell 3000, which the company describes as widely followed by mutual funds and other investors. Syntec Optics highlights that index inclusion can increase attention and perceived credibility among major investment funds.
Syntec Optics (Nasdaq: OPTX) announced new orders for two additional ballistic-grade display windows used in soldier Augmented Reality systems, expanding its defense optics product lineup. The new awards cover separate windows for advanced eye-tracking and specialized illumination in AI-enabled AR headsets.
According to Syntec Optics, these domestically sourced, NDAA-compliant optics are designed to protect high-fidelity eye tracking and support mission-critical AI tasks, which help filter and highlight relevant battlefield information, and are viewed internally as the start of a potential decade-long supply program.
Syntec Optics (NASDAQ: OPTX) reported a 40% increase in orders for its missile laser guidance optical sub-systems, driven by replenishment of U.S. and allied defense inventories.
Total order value now exceeds $1.2 million, up from nearly $850,000, with about 23% already fulfilled as the defense platform continues to scale.
Syntec Optics (NASDAQ: OPTX) received a new order to modularize and expand its ballistic optics product line for advanced AR/VR glasses used by the U.S. military. The optics support AI-enhanced, mixed-reality systems that integrate real-time data and protect mission-critical battlefield information projected into the warfighter’s field of view.
The modular architecture is intended to serve a broader family of AR glasses across branches and applications, offering features such as six degrees of freedom, enhanced spatial awareness, night vision, and thermal fusion. Management describes this AI-driven AR initiative as the most significant growth opportunity in Syntec’s 25-year history, within a defense AR/VR market projected to grow from USD 1.68 billion in 2025 to USD 4.34 billion by 2030 at a 20.9% CAGR.
Syntec Optics (Nasdaq: OPTX) announced over $4 million in new U.S. life sciences purchase orders across diversified BioMed platforms. These contracts, in addition to previously announced $4.6 million in laser blood analysis optics orders, support applications in surgical robotics, DNA sequencing, biomedical visualization, ophthalmology, and veterinary care.
According to Syntec Optics, advanced optical, optomechanical, molded, and electro-optic capabilities will help complete these long-life-cycle 2026 orders, reinforcing its role in U.S. healthcare, defense tech, and space tech markets.
Syntec Optics (Nasdaq: OPTX) announced nearly $2.4 million in new space optics purchase orders for a product line scaled for higher production in Q1 2026, supporting weekly Low Earth Orbit satellite launches.
This expands a prior nearly $1.9 million order, bringing recent awards to about $4.3 million, with delivery expected before mid-next quarter.
Syntec Optics (Nasdaq: OPTX) announced a new $4.6 million purchase order to continue manufacturing advanced laser blood-test cartridges and optical reader subsystems for critical-care analyzers used in global clinics and hospitals.
About half of this order has shipped, with full delivery targeted by Q3.